News Focus
News Focus
icon url

jq1234

04/16/12 3:41 PM

#140271 RE: bladerunner1717 #140270

I didn't listen to the call. From press release, ECYT fund and finish ph3 OC trial which is a relatively large trial, MRK basically take over everything else. NSCLC ph2 is a much smaller trial. It would be interesting to see what MRK do.